BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 23544271)

  • 1. Glucocorticoid-induced hypertension and cardiac injury: effects of mineralocorticoid and glucocorticoid receptor antagonism.
    Hattori T; Murase T; Iwase E; Takahashi K; Ohtake M; Tsuboi K; Ohtake M; Miyachi M; Murohara T; Nagata K
    Nagoya J Med Sci; 2013 Feb; 75(1-2):81-92. PubMed ID: 23544271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoids activate cardiac mineralocorticoid receptors in adrenalectomized Dahl salt-sensitive rats.
    Ohtake M; Hattori T; Murase T; Takahashi K; Takatsu M; Ohtake M; Miyachi M; Watanabe S; Cheng XW; Murohara T; Nagata K
    Nagoya J Med Sci; 2014 Feb; 76(1-2):59-72. PubMed ID: 25129992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does glucocorticoid receptor blockade exacerbate tissue damage after mineralocorticoid/salt administration?
    Rickard AJ; Funder JW; Morgan J; Fuller PJ; Young MJ
    Endocrinology; 2007 Oct; 148(10):4829-35. PubMed ID: 17640982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mineralocorticoid receptor blockade prevents Western diet-induced diastolic dysfunction in female mice.
    Bostick B; Habibi J; DeMarco VG; Jia G; Domeier TL; Lambert MD; Aroor AR; Nistala R; Bender SB; Garro M; Hayden MR; Ma L; Manrique C; Sowers JR
    Am J Physiol Heart Circ Physiol; 2015 May; 308(9):H1126-35. PubMed ID: 25747754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II-induced cardiac, renal, and vascular injury.
    Luther JM; Luo P; Wang Z; Cohen SE; Kim HS; Fogo AB; Brown NJ
    Kidney Int; 2012 Sep; 82(6):643-51. PubMed ID: 22622494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressant-like effects of mineralocorticoid but not glucocorticoid antagonists in the lateral septum: interactions with the serotonergic system.
    Mostalac-Preciado CR; de Gortari P; López-Rubalcava C
    Behav Brain Res; 2011 Sep; 223(1):88-98. PubMed ID: 21515309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenocorticosteroid receptor blockade and excitotoxic challenge regulate adrenocorticosteroid receptor mRNA levels in hippocampus.
    McCullers DL; Herman JP
    J Neurosci Res; 2001 May; 64(3):277-83. PubMed ID: 11319772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenocorticotrophin-induced hypertension: effects of mineralocorticoid and glucocorticoid receptor antagonism.
    Li M; Wen C; Fraser T; Whitworth JA
    J Hypertens; 1999 Mar; 17(3):419-26. PubMed ID: 10100081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin and mineralocorticoid receptor antagonism attenuates cardiac oxidative stress in angiotensin II-infused rats.
    Minas JN; Thorwald MA; Conte D; Vázquez-Medina JP; Nishiyama A; Ortiz RM
    Clin Exp Pharmacol Physiol; 2015 Nov; 42(11):1178-88. PubMed ID: 26234762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Traumatic brain injury regulates adrenocorticosteroid receptor mRNA levels in rat hippocampus.
    McCullers DL; Sullivan PG; Scheff SW; Herman JP
    Brain Res; 2002 Aug; 947(1):41-9. PubMed ID: 12144851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the glucocorticoid receptor in mineralocorticoid/salt-mediated cardiac fibrosis.
    Rickard AJ; Funder JW; Fuller PJ; Young MJ
    Endocrinology; 2006 Dec; 147(12):5901-6. PubMed ID: 16990342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats.
    Nagata K; Obata K; Xu J; Ichihara S; Noda A; Kimata H; Kato T; Izawa H; Murohara T; Yokota M
    Hypertension; 2006 Apr; 47(4):656-64. PubMed ID: 16505208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mifepristone protects CA1 hippocampal neurons following traumatic brain injury in rat.
    McCullers DL; Sullivan PG; Scheff SW; Herman JP
    Neuroscience; 2002; 109(2):219-30. PubMed ID: 11801359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockage of glucocorticoid, but not mineralocorticoid receptors prevents the persistent increase in circulating basal corticosterone concentrations following stress in the rat.
    Moldow RL; Beck KD; Weaver S; Servatius RJ
    Neurosci Lett; 2005 Feb; 374(1):25-8. PubMed ID: 15631890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid receptor mediated the propofol self-administration by dopamine D1 receptor in nucleus accumbens.
    Wu B; Liang Y; Dong Z; Chen Z; Zhang G; Lin W; Wang S; Wang B; Ge RS; Lian Q
    Neuroscience; 2016 Jul; 328():184-93. PubMed ID: 27126557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoid receptor but not mineralocorticoid receptor mediates the activation of ERK pathway and CREB during morphine withdrawal.
    Navarro-Zaragoza J; Laorden ML; Milanés MV
    Addict Biol; 2017 Mar; 22(2):342-353. PubMed ID: 26598419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid and mineralocorticoid receptors regulate paracellular permeability in a primary cultured gill epithelium.
    Kelly SP; Chasiotis H
    J Exp Biol; 2011 Jul; 214(Pt 14):2308-18. PubMed ID: 21697422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paradoxical mineralocorticoid receptor activation and left ventricular diastolic dysfunction under high oxidative stress conditions.
    Wang H; Shimosawa T; Matsui H; Kaneko T; Ogura S; Uetake Y; Takenaka K; Yatomi Y; Fujita T
    J Hypertens; 2008 Jul; 26(7):1453-62. PubMed ID: 18551023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-stress effects of combined block of glucocorticoid and mineralocorticoid receptors in the paraventricular nucleus of the hypothalamus.
    Ding H; Cui SY; Cui XY; Liu YT; Hu X; Zhao HL; Qin Y; Kurban N; Zhang YH
    Br J Pharmacol; 2021 Sep; 178(18):3696-3707. PubMed ID: 33908038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additive amelioration of oxidative stress and cardiac function by combined mineralocorticoid and angiotensin receptor blockers in postinfarct failing hearts.
    Noda K; Kobara M; Hamada J; Yoshifuji Y; Shiraishi T; Tanaka T; Wang J; Toba H; Nakata T
    J Cardiovasc Pharmacol; 2012 Aug; 60(2):140-9. PubMed ID: 22549451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.